MedTech Dive - Latest News

Dexcom receives warning letter based on FDA inspections of 2 plants

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.

Mar 10, 2025 - 15:38
 0
Dexcom receives warning letter based on FDA inspections of 2 plants

The company does not expect the warning letter to materially impact its manufacturing capacity, sales or ability to seek clearance for new products.

Read More

Tags:

Previous Article

France awards 220MW rooftop solar PV in undersubscribed tender

Next Article

Capital board makes noncash provisions, impacting 2024 profits

Related Posts

Orthofix’s fired execs’ lewd, ‘graphic’ texts surface in legal battle

Orthofix’s fired execs’ lewd, ‘graphic’ texts surface i...

Mar 10, 2025  0

Thermo Fisher lays off another 300 workers in Massachusetts

Thermo Fisher lays off another 300 workers in Massachus...

Feb 9, 2025  0

BD plans split from life science business to fuel medtech investment

BD plans split from life science business to fuel medte...

Feb 9, 2025  0